Literature DB >> 1553252

Pharmacokinetics of amoxycillin in elderly in-patients.

R Janknegt1, J Boogaard-Van den Born, B A Hameleers, P M Hooymans, J Rang, C A Smits, M E Willems-Thissen.   

Abstract

The pharmacokinetics of amoxycillin (500 mg) given by intravenous injection and as two oral formulations on three consecutive days were investigated in eight frail elderly in-patients. Marked interindividual variation was found in all kinetic parameters after intravenous injection. The area under the curve (AUC) ranged from 32 to 155 mg.l-1.h and the distribution volume ranged from 13 to 37.1. The mean plasma clearance was 109 ml/min (range 53 to 255 ml/min). Elimination half-life ranged from 1.6 to 3.0 h (mean 2.4 h). The absolute bioavailability after oral administration was highly variable and ranged from 24 to 86% (mean 55%). The bioavailability of the two formulations was not significantly different. The performance of a pharmacokinetic study in these patients was very difficult, regarding their inability to tolerate an intravenous infusion, incontinence, disruption of everyday routine and problems with drinking the required volume of water.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1553252     DOI: 10.1007/bf01989222

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  4 in total

1.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

2.  Bioavailability study of a new amoxicillin tablet designed for several modes of oral administration.

Authors:  W R Cortvriendt; J S Verschoor; W Hespe
Journal:  Arzneimittelforschung       Date:  1987-08

Review 3.  Amoxycillin injectable: a review of its antibacterial spectrum, pharmacokinetics and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-09       Impact factor: 9.546

4.  Intra- and inter-individual variation in pharmacokinetics of intravenously infused amoxycillin and ampicillin to elderly volunteers.

Authors:  J Sjövall; G Alván; B Huitfeldt
Journal:  Br J Clin Pharmacol       Date:  1986-02       Impact factor: 4.335

  4 in total
  4 in total

Review 1.  The treatment of staphylococcal infections with special reference to pharmacokinetic, pharmacodynamic and pharmacoeconomic considerations.

Authors:  R Janknegt
Journal:  Pharm World Sci       Date:  1997-06

2.  Scaling beta-lactam antimicrobial pharmacokinetics from early life to old age.

Authors:  Dagan O Lonsdale; Emma H Baker; Karin Kipper; Charlotte Barker; Barbara Philips; Andrew Rhodes; Mike Sharland; Joseph F Standing
Journal:  Br J Clin Pharmacol       Date:  2018-11-26       Impact factor: 4.335

3.  The impact of frailty on pharmacokinetics in older people: using gentamicin population pharmacokinetic modeling to investigate changes in renal drug clearance by glomerular filtration.

Authors:  Claire Johnston; Sarah N Hilmer; Andrew J McLachlan; Slade T Matthews; Peter R Carroll; Carl M Kirkpatrick
Journal:  Eur J Clin Pharmacol       Date:  2014-02-14       Impact factor: 2.953

4.  Urinary concentrations of fosfomycin after a single 3 g dose of fosfomycin to elderly nursing-home patients.

Authors:  R Janknegt; P M Hooymans; G T Fabius; M K Nohlmans-Paulssen; C Machielsen; J Boogaard-van den Born; J Rang; C A Smits; M E Willems-Thissen; A Krommenhoek
Journal:  Pharm World Sci       Date:  1994-06-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.